239 related articles for article (PubMed ID: 12384379)
21. In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms.
Miceli MH; Bernardo SM; Lee SA
Int J Antimicrob Agents; 2009 Oct; 34(4):326-32. PubMed ID: 19515537
[TBL] [Abstract][Full Text] [Related]
22. In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms.
Kawai A; Yamagishi Y; Mikamo H
J Infect Chemother; 2015 Sep; 21(9):647-53. PubMed ID: 26141813
[TBL] [Abstract][Full Text] [Related]
23. Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins.
Soustre J; Rodier MH; Imbert-Bouyer S; Daniault G; Imbert C
J Antimicrob Chemother; 2004 Mar; 53(3):522-5. PubMed ID: 14749343
[TBL] [Abstract][Full Text] [Related]
24. In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilms.
Sarkar S; Uppuluri P; Pierce CG; Lopez-Ribot JL
Antimicrob Agents Chemother; 2014; 58(2):1183-6. PubMed ID: 24217700
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.
Arikan S; Sancak B; Hascelik G
Med Mycol; 2005 Mar; 43(2):171-8. PubMed ID: 15832560
[TBL] [Abstract][Full Text] [Related]
26. A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms.
DiDone L; Oga D; Krysan DJ
Yeast; 2011 Aug; 28(8):561-8. PubMed ID: 21674619
[TBL] [Abstract][Full Text] [Related]
27. Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles.
Shinde RB; Raut JS; Chauhan NM; Karuppayil SM
Braz J Infect Dis; 2013; 17(4):395-400. PubMed ID: 23602464
[TBL] [Abstract][Full Text] [Related]
28. Interaction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitro.
Liu W; Li L; Sun Y; Chen W; Wan Z; Li R; Liu W
Antimicrob Agents Chemother; 2012 Dec; 56(12):6414-6. PubMed ID: 23027186
[TBL] [Abstract][Full Text] [Related]
29. Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.
Simitsopoulou M; Kyrpitzi D; Velegraki A; Walsh TJ; Roilides E
Antimicrob Agents Chemother; 2014 Aug; 58(8):4953-6. PubMed ID: 24890585
[TBL] [Abstract][Full Text] [Related]
30. Caspofungin activity against clinical isolates of fluconazole-resistant Candida.
Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
J Clin Microbiol; 2003 Dec; 41(12):5729-31. PubMed ID: 14662968
[TBL] [Abstract][Full Text] [Related]
31. In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.
Katragkou A; McCarthy M; Alexander EL; Antachopoulos C; Meletiadis J; Jabra-Rizk MA; Petraitis V; Roilides E; Walsh TJ
J Antimicrob Chemother; 2015 Feb; 70(2):470-8. PubMed ID: 25288679
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm.
Pesee S; Angkananuwat C; Tancharoensukjit S; Muanmai S; Sirivan P; Bubphawas M; Tanarerkchai N
Med Mycol; 2016 May; 54(4):384-93. PubMed ID: 26768371
[TBL] [Abstract][Full Text] [Related]
33. Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro.
Franzot SP; Casadevall A
Antimicrob Agents Chemother; 1997 Feb; 41(2):331-6. PubMed ID: 9021188
[TBL] [Abstract][Full Text] [Related]
34. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.
Vediyappan G; Rossignol T; d'Enfert C
Antimicrob Agents Chemother; 2010 May; 54(5):2096-111. PubMed ID: 20194705
[TBL] [Abstract][Full Text] [Related]
35. In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.
Xia J; Qian F; Xu W; Zhang Z; Wei X
Biofouling; 2017 Apr; 33(4):283-293. PubMed ID: 28317391
[TBL] [Abstract][Full Text] [Related]
36. Liposomal amphotericin B eradicates Candida albicans biofilm in a continuous catheter flow model.
Seidler M; Salvenmoser S; Müller FM
FEMS Yeast Res; 2010 Jun; 10(4):492-5. PubMed ID: 20345899
[TBL] [Abstract][Full Text] [Related]
37. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.
Ramage G; Vande Walle K; Wickes BL; López-Ribot JL
Antimicrob Agents Chemother; 2001 Sep; 45(9):2475-9. PubMed ID: 11502517
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance.
Bachmann SP; Patterson TF; López-Ribot JL
J Clin Microbiol; 2002 Jun; 40(6):2228-30. PubMed ID: 12037093
[TBL] [Abstract][Full Text] [Related]
39. Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans.
Ellepola AN; Khajah R; Jayatilake S; Samaranayake L; Sharma P; Khan Z
J Appl Oral Sci; 2015; 23(4):412-8. PubMed ID: 26398514
[TBL] [Abstract][Full Text] [Related]
40. Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms.
Khan MS; Ahmad I
J Antimicrob Chemother; 2012 Mar; 67(3):618-21. PubMed ID: 22167241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
